Four-type HPV Vaccine Gardasil(R) Is Also Effective In Men
Nov 21st 2008Drug InformationCervical Cancer
The four-type (6,11,16,18) human papillomavirus (HPV) vaccine Gardasil® is also effective in men according to the primary analysis from a pivotal phase III clinical study. In previously uninfected men aged 16 to 26 years*, Gardasil® prevented 90% (95%CI: 69, 98) of external genital lesions caused by HPV types 6, 11, 16 or 18. The data were presented this week at the congress of the European Research Organisation on Genital Infection and Neoplasia (EUROGIN) in Nice, France.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
